FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308121870> ?p ?o ?g. }

• W4308121870 endingPage "3434" @default.
• W4308121870 startingPage "3434" @default.
• W4308121870 abstract "Lung cancer is among the most common and lethal cancers and warrants novel therapeutic approaches to improving patient outcomes. Although immune checkpoint inhibitors (ICIs) have demonstrated substantial clinical benefits, most patients remain unresponsive to currently approved ICIs or develop resistance after initial response. Many ongoing clinical studies are investigating combination therapies to address the limited efficacy of ICIs. Here, we have assessed whether p53 gene therapy via a tumor-targeting nanomedicine (termed SGT-53) can augment anti-programmed cell death-1 (PD-1) immunotherapy to expand its use in non-responding patients. Using syngeneic mouse models of lung cancers that are resistant to anti-PD-1, we demonstrate that restoration of normal p53 function potentiates anti-PD-1 to inhibit tumor growth and prolong survival of tumor-bearing animals. Our data indicate that SGT-53 can restore effective immune responses against lung cancer cells by reducing immuno-suppressive cells (M2 macrophages and regulatory T cells) and by downregulating immunosuppressive molecules (e.g., galectin-1, a negative regulator of T cell activation and survival) while increasing activity of cytotoxic T cells. These results suggest that combining SGT-53 with anti-PD-1 immunotherapy could increase the fraction of lung cancer patients that responds to anti-PD-1 therapy and support evaluation of this combination particularly in patients with ICI-resistant lung cancers." @default.
• W4308121870 created "2022-11-08" @default.
• W4308121870 creator A5009099475 @default.
• W4308121870 creator A5022326414 @default.
• W4308121870 creator A5039264253 @default.
• W4308121870 creator A5063496431 @default.
• W4308121870 creator A5088812559 @default.
• W4308121870 date "2022-10-31" @default.
• W4308121870 modified "2023-10-12" @default.
• W4308121870 title "A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models" @default.
• W4308121870 cites W1511621323 @default.
• W4308121870 cites W1788030720 @default.
• W4308121870 cites W1835280798 @default.
• W4308121870 cites W1904548309 @default.
• W4308121870 cites W1963863438 @default.
• W4308121870 cites W1968091639 @default.
• W4308121870 cites W1974692537 @default.
• W4308121870 cites W2023568521 @default.
• W4308121870 cites W2044835625 @default.
• W4308121870 cites W2054741438 @default.
• W4308121870 cites W2055818547 @default.
• W4308121870 cites W2064573340 @default.
• W4308121870 cites W2099791897 @default.
• W4308121870 cites W2110436086 @default.
• W4308121870 cites W2113880766 @default.
• W4308121870 cites W2133156689 @default.
• W4308121870 cites W2141123924 @default.
• W4308121870 cites W2157672076 @default.
• W4308121870 cites W2157830527 @default.
• W4308121870 cites W2164845904 @default.
• W4308121870 cites W2332433189 @default.
• W4308121870 cites W2480642725 @default.
• W4308121870 cites W2509197499 @default.
• W4308121870 cites W2539229861 @default.
• W4308121870 cites W2553246368 @default.
• W4308121870 cites W2587486634 @default.
• W4308121870 cites W2608165987 @default.
• W4308121870 cites W2770332728 @default.
• W4308121870 cites W2784012638 @default.
• W4308121870 cites W2795708883 @default.
• W4308121870 cites W2799455970 @default.
• W4308121870 cites W2808205146 @default.
• W4308121870 cites W2903902446 @default.
• W4308121870 cites W2905077870 @default.
• W4308121870 cites W2924359886 @default.
• W4308121870 cites W2945224722 @default.
• W4308121870 cites W2954288760 @default.
• W4308121870 cites W2965576600 @default.
• W4308121870 cites W2976035920 @default.
• W4308121870 cites W2983070298 @default.
• W4308121870 cites W2986308648 @default.
• W4308121870 cites W2994679067 @default.
• W4308121870 cites W2994690496 @default.
• W4308121870 cites W2994732623 @default.
• W4308121870 cites W2996846865 @default.
• W4308121870 cites W3000319768 @default.
• W4308121870 cites W3009145316 @default.
• W4308121870 cites W3106806530 @default.
• W4308121870 cites W3128646645 @default.
• W4308121870 cites W3131151008 @default.
• W4308121870 cites W3171471474 @default.
• W4308121870 cites W4235465754 @default.
• W4308121870 cites W4294718043 @default.
• W4308121870 doi "https://doi.org/10.3390/cells11213434" @default.
• W4308121870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36359830" @default.
• W4308121870 hasPublicationYear "2022" @default.
• W4308121870 type Work @default.
• W4308121870 citedByCount "3" @default.
• W4308121870 countsByYear W43081218702023 @default.
• W4308121870 crossrefType "journal-article" @default.
• W4308121870 hasAuthorship W4308121870A5009099475 @default.
• W4308121870 hasAuthorship W4308121870A5022326414 @default.
• W4308121870 hasAuthorship W4308121870A5039264253 @default.
• W4308121870 hasAuthorship W4308121870A5063496431 @default.
• W4308121870 hasAuthorship W4308121870A5088812559 @default.
• W4308121870 hasBestOaLocation W43081218701 @default.
• W4308121870 hasConcept C121608353 @default.
• W4308121870 hasConcept C126322002 @default.
• W4308121870 hasConcept C143998085 @default.
• W4308121870 hasConcept C154317977 @default.
• W4308121870 hasConcept C202751555 @default.
• W4308121870 hasConcept C203014093 @default.
• W4308121870 hasConcept C2776256026 @default.
• W4308121870 hasConcept C2776999253 @default.
• W4308121870 hasConcept C2777701055 @default.
• W4308121870 hasConcept C2780252810 @default.
• W4308121870 hasConcept C2781053074 @default.
• W4308121870 hasConcept C502942594 @default.
• W4308121870 hasConcept C55493867 @default.
• W4308121870 hasConcept C71924100 @default.
• W4308121870 hasConcept C86803240 @default.
• W4308121870 hasConcept C8891405 @default.
• W4308121870 hasConcept C98274493 @default.
• W4308121870 hasConceptScore W4308121870C121608353 @default.
• W4308121870 hasConceptScore W4308121870C126322002 @default.
• W4308121870 hasConceptScore W4308121870C143998085 @default.
• W4308121870 hasConceptScore W4308121870C154317977 @default.
• W4308121870 hasConceptScore W4308121870C202751555 @default.

• next